1389313-40-9

Usage

Uses

Used in Pharmaceutical Research:
2-(5-(TrifluoroMethoxy)-1H-indol-3-yl)ethanaMine hydrochloride is utilized as a research tool for understanding the mechanisms of the 5-HT2A receptor and its involvement in various central nervous system functions. Its application aids in the exploration of novel treatment strategies for neurological and psychiatric conditions.
Used in Neurological and Psychiatric Conditions:
In the field of neurology and psychiatry, 2-(5-(TrifluoroMethoxy)-1H-indol-3-yl)ethanaMine hydrochloride is used as a potential therapeutic agent for conditions such as depression, anxiety, and schizophrenia. Its agonistic effect on the 5-HT2A receptor suggests it may contribute to the modulation of mood, perception, and cognitive processes, offering new avenues for treatment.
Used in Preclinical Studies:
This chemical compound is employed in preclinical studies to evaluate its efficacy and safety in animal models. These studies are crucial for establishing a foundation of knowledge regarding its potential benefits and risks before progressing to human trials.
Used in Drug Development:
2-(5-(TrifluoroMethoxy)-1H-indol-3-yl)ethanaMine hydrochloride serves as a lead compound in drug development, with the aim of creating new medications that can target the 5-HT2A receptor more effectively. Its unique properties may lead to the design of drugs with fewer side effects and greater selectivity for the receptor.
Used in Chemical Synthesis:
In the chemical synthesis industry, 2-(5-(TrifluoroMethoxy)-1H-indol-3-yl)ethanaMine hydrochloride may be used as a starting material or intermediate in the production of other related compounds with potential therapeutic applications. Its synthesis can also provide insights into the development of new chemical entities with similar mechanisms of action.